Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Medical Incubator Japan K.K., based in Tokyo, focuses on investing in healthcare startups. The firm targets both domestic and international companies, emphasizing groundbreaking pharmaceuticals and medical services. They manage a portfolio of 11 companies, aiming to generate returns while providing hope to patients.
The firm invests in startups developing first-in-class or best-in-class pharmaceuticals, including regenerative medicine, gene therapy, and small molecules. Additionally, they support innovations in medical services through devices and digital health solutions. Check sizes and specific investment stages are not disclosed.
Notable portfolio companies include IgGenix Inc., developing human antibodies for allergies; Hoba Therapeutics ApS, focused on protein therapeutics for neuropathic pain; and SanBio Co., Ltd., which specializes in regenerative cell therapies. Other companies include Modalis, Inc., Cellgentec, Inc., and Heartseed, Inc., among others.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.